Freitag Gregory Gene
CIK 0001492710
Director
Filings
14
Latest Mar 3, 2026
Issuers covered
3
Showing
14 of 14
Page 1
Track record
6 of 6 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 6 | 50% | -0.1% | -0.6% | +12.2% | -10.5% |
| 90 days | 6 | 100% | +24.9% | +26.0% | +34.9% | +5.3% |
| 180 days | 6 | 67% | +12.5% | +28.0% | +34.2% | -45.8% |
| 365 days | 6 | 67% | -6.3% | +20.9% | +32.5% | -96.6% |
Issuers
Companies where Freitag Gregory Gene has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| AXGN | Axogen, Inc. | 6 | Jun 6, 2024 |
| PDSB | Pds Biotechnology Corp | 6 | Mar 3, 2026 |
| ZVSA | Zyversa Therapeutics, Inc. | 2 | Jul 15, 2025 |
All filings
14 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|